Related Experiment Video
Updated: May 19, 2026

Differentiated Mouse Adipocytes in Primary Culture: A Model of Insulin Resistance
Published on: February 17, 2023
The transcriptional coactivators p/CIP and SRC-1 control insulin resistance through IRS1 in obesity models
Zhiyong Wang1, O Jameel Shah, Tony Hunter
1Molecular and Cell Biology Laboratory, Salk Institute for Biological Studies, La Jolla, California, United States of America. zwang@salk.edu
Abstract:
Three p160 family members, p/CIP, SRC1, and TIF2, have been identified as transcriptional coactivators for nuclear hormone receptors and other transcription factors in vitro. In a previous study, we reported initial characterization of the obesity-resistant phenotypes of p/CIP and SRC-1 double knockout (DKO) mice, which exhibit increased energy expenditure, and suggested that nuclear hormone receptor target genes were involved in these phenotypes. In this study, we demonstrate that p/CIP and SRC1 control insulin signaling in a cell-autonomous manner both in vitro and in vivo. Genetic deletion of p/CIP and SRC-1 increases glucose uptake and enhances insulin sensitivity in both regular chow- and high fat diet-fed DKO mice despite increased food intake. Interestingly, we discover that loss of p/CIP and SRC-1 results in resistance to age-related obesity and glucose intolerance. We show that expression levels of a key insulin signaling component, insulin receptor substrate 1 (IRS1), are significantly increased in two cell lines representing fat and muscle lineages with p/CIP and SRC-1 deletions and in white adipose tissue and skeletal muscle of DKO mice; this may account for increased glucose metabolism and insulin sensitivity. This is the first evidence that the p160 coactivators control insulin signaling and glucose metabolism through IRS1. Therefore, our studies indicate that p/CIP and SRC-1 are potential therapeutic targets not only for obesity but also for diabetes.
Insights
The p160 coactivators, p/CIP and SRC-1, are crucial for regulating insulin signaling and glucose metabolism. Their absence enhances insulin sensitivity and glucose uptake, offering potential therapeutic targets for obesity and diabetes.
Area of Science:
- Molecular Biology
- Endocrinology
- Metabolic Research
Background:
- p160 family members p/CIP, SRC1, and TIF2 function as transcriptional coactivators.
- Previous studies showed obesity resistance in p/CIP and SRC-1 double knockout (DKO) mice, suggesting nuclear hormone receptor involvement.
- The precise role of these coactivators in metabolic regulation remained unclear.
Purpose of the Study:
- To investigate the role of p/CIP and SRC-1 in insulin signaling and glucose metabolism.
- To determine the in vitro and in vivo effects of p/CIP and SRC-1 deletion on metabolic parameters.
- To identify the molecular mechanisms underlying the metabolic phenotypes observed in DKO mice.
Main Methods:
- Generation and analysis of p/CIP and SRC-1 double knockout (DKO) mice.
- In vitro studies using cell lines representing fat and muscle lineages.
- Assessment of glucose uptake, insulin sensitivity, and energy expenditure.
- Analysis of insulin receptor substrate 1 (IRS1) expression levels in various tissues and cell types.
Main Results:
- Genetic deletion of p/CIP and SRC-1 enhanced insulin sensitivity and glucose uptake in DKO mice, irrespective of diet.
- DKO mice exhibited resistance to age-related obesity and glucose intolerance.
- Increased expression of insulin receptor substrate 1 (IRS1) was observed in fat and muscle cells and tissues of DKO mice, correlating with improved glucose metabolism.
Conclusions:
- p/CIP and SRC-1 play a critical role in controlling insulin signaling and glucose metabolism through IRS1.
- The p160 coactivators regulate metabolic homeostasis in a cell-autonomous manner.
- p/CIP and SRC-1 represent potential therapeutic targets for obesity and diabetes treatment.
Related Concept Videos
Cell Specific Gene Expression
Insulin: The Receptor and Signaling Pathways
Co-activators and Co-repressors
Co-activators and Co-repressors
Regulation of the Unfolded Protein Response
PI3K/mTOR/AKT Signaling Pathway
